| MAN JAPAN COREALPHA EQUITY D H USD | RVI JAPÓN | 34,50% | 100,47% | 238,75% | 377,14% |
| JANUS HENDERSON GLOBAL TECHNOLOGY AND INNOVATION A2 EUR HEDGED | RVI TECNOLOGÍA | 11,81% | 99,09% | 47,98% | 374,49% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 26,65% | 98,45% | 75,59% | 374,17% |
| GOLDMAN SACHS JAPAN EQUITY PARTNERS PORTFOLIO P H USD CAP | RVI JAPÓN | 22,10% | 78,87% | 107,27% | 373,93% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 26,94% | 98,13% | 76,22% | 373,59% |
| POLAR CAPITAL JAPAN VALUE R USD DIS HEDGED | RVI JAPÓN VALOR | 35,93% | 105,89% | 209,82% | 372,75% |
| UBS (LUX) EQUITY SICAV - USA GROWTH (USD) I-A1-ACC | RVI USA CRECIMIENTO | 2,27% | 66,01% | 53,11% | 372,63% |
| PICTET - ROBOTICS R EUR | RVI TECNOLOGÍA | 18,59% | 95,61% | 69,30% | 372,54% |
| PRIVILEDGE - ALPHA JAPAN (USD) P CAP SYST. HDG | RVI JAPÓN | 16,54% | 86,29% | 131,45% | 372,51% |
| PICTET - ROBOTICS R USD | RVI TECNOLOGÍA | 18,47% | 94,90% | 69,36% | 371,62% |
